# Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

> **NCT01552915** · PHASE4 · COMPLETED · sponsor: **Shire** · enrollment: 464 (actual)

## Conditions studied

- Attention-deficit/Hyperactivity Disorder

## Interventions

- **DRUG:** Lisdexamfetamine dimesylate
- **DRUG:** Methylphenidate Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01552915
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-17
- **Primary completion:** 2014-01-22
- **Final completion:** 2014-01-22
- **Target enrollment:** 464 (ACTUAL)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01552915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01552915, "Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01552915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*